emergent logo.jpg
Emergent BioSolutions to Participate in Investor Conferences
August 23, 2021 16:05 ET | Emergent BioSolutions
GAITHERSBURG, Md., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following...
emergent logo.jpg
Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021
July 15, 2021 06:30 ET | Emergent BioSolutions
GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial...
LOGO.jpg
EBS UPDATED DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Informs Emergent BioSolutions Inc. Investors of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday – EBS
June 18, 2021 10:11 ET | The Rosen Law Firm PA
NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24,...
emergent logo.jpg
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization
June 11, 2021 16:35 ET | Emergent BioSolutions
Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production GAITHERSBURG, Md., June 11, 2021 (GLOBE...
LOGO.jpg
EBS FINAL DEADLINE NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action – EBS
June 11, 2021 12:03 ET | The Rosen Law Firm PA
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24,...
LOGO.jpg
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EBS
June 02, 2021 16:11 ET | The Rosen Law Firm PA
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24,...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
June 02, 2021 11:00 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 26, 2021 11:45 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, May 26, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 21, 2021 11:15 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, May 21, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
LOGO.jpg
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EBS
May 14, 2021 19:15 ET | The Rosen Law Firm PA
NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020...